s), Abstr. 2271.Rea, D.; Etienne, G.; Corm, S.; Cony-Makhoul, P.; Gardembas, M.; Legros, L.; Dubruille, V.;Hayette, S.; Mahon, F.X.; Cayuela, J.M. & Nicolini, F.E. (2009). Imatinib doseescalation for chronic phase-chronic myelogenous leukaemia patients in primarysuboptimal response to imatinib 400 mg daily standard therapy. Leukemia, Vol. 23(6), pp. 1193-1196.Rudzki, J. ...

Chronic myelomonocytic leukaemia is an atypical myeloproliferative disorder with a natural history of progression to acute myeloid leukaemia, a complex and poorly understood response by the bone marrow to stress. Cardiac surgery activates many inflammatory cascades and may precipitate a systemic inflammatory response syndrome. We present a case of undiagnosed chronic myelomonocytic leukaemia wh...

Microarray gene expression profiles of fresh clinical samples of chronic myeloid leukaemia in chronic phase, acute promyelocytic leukaemia and acute monocytic leukaemia were compared with profiles from cell lines representing the corresponding types of leukaemia (K562, NB4, HL60). In a hierarchical clustering analysis, all clinical samples clustered separately from the cell lines, regardless of...

Chronic myeloid leukaemia (CML) is a malignant clonal disorder of the haematopoietic stem cell. Treatment of CML patients with interferon alpha (IFN-alpha) has induced haematological and cytogenetic remission. Interferons transcriptionally activate target genes through the JAK-STAT and interferon regulated factors (IRFs) family pathways. Interferon regulated factor-1 (IRF-1) is a transcriptiona...

References BRONSON, W.R., DE VITA, V.T., CARBONE, P.P. & COTLOVE, E. (1966) Pseudo-hyperkalemia due to release of potassium from white blood cells during clotting. New England Journal of Medicine, 274, No. 7; 369. CLAIN, A. (1973) (Ed.) Hamilton Bailey's Demonstrations of Physical Signs in Clinical Surgery. 15th Edn, p.333. John Wright & Son Ltd, Bristol. COORAY, G.H. (1952) Spontaneous rupture...

background: recently, the anti cancer effect of chromene derivatives in different cell types has been reported. in this study, we report some derivatives of dihydropyrano[c]chromenes with growth inhibitory and apoptotic activity against k562, chronic myeloid leukaemia (cml). methods: the cells were seeded in 96-well plates at 1×105 cells/well and treated with different concentrations of the dih...